Cellular remodeling during progression of dilation involves focal adhesion contact reorganization. However, the signaling mechanisms and structural consequences leading to impaired cardiomyocyte adhesion are poorly defined. These events were studied in
tropomodulin-overexpressing transgenic mice that develop
dilated cardiomyopathy associated with chronic elevation of intracellular
calcium. Analysis of
tropomodulin-overexpressing transgenic hearts by immunoblot and confocal microscopy revealed activation and redistribution of signaling molecules known to regulate adhesion.
Calcium-dependent pyk2/related focal adhesion
tyrosine kinase (RAFTK) showed changes in expression and phosphorylation state, similar to changes observed for a related downstream target molecule of pyk2/RAFTK termed
focal adhesion kinase.
Paxillin, the target substrate molecule for
focal adhesion kinase phosphorylation, was redistributed in
tropomodulin-overexpressing transgenic hearts with enhanced
paxillin phosphorylation and cleavage. Certain aspects of the in vivo signaling phenotype including increased
paxillin phosphorylation could be recapitulated in vitro using neonatal rat cardiomyocytes infected with recombinant adenovirus to overexpress
tropomodulin. In addition, increasing intracellular
calcium levels with
ionomycin induced pyk2/RAFTK phosphorylation, and adenovirally mediated expression of wild-type pyk2/RAFTK resulted in increased phospho-pyk2/RAFTK levels and concomitant
paxillin phosphorylation. Collectively, these results delineate a cardiomyocyte signaling pathway associated with dilation that has potential relevance for cardiac remodeling, focal adhesion reorganization, and loss of contractility.